Tag: IT

2025 m. balandžio 28 d. eiliniame visuotiniame akcininkų susirinkime naujai dvejų metų kadencijai perrinkti penki praeitos Telia Lietuva, AB (toliau – „Telia Lietuva“ arba Bendrovė) valdybos nariai – Stefan Backman, Claes Nycander, Hannu-Matti Mäkinen, Leda Iržikevičienė ir Mindaugas Glodas, bei išrinkta nauja valdybos narė Annelie Lakner. Pirmajame naujos kadencijos posėdyje valdyba Bendrovės valdybos pirmininku perrinko Stefan Backman ir paskyrė Audito bei Atlygio komitetų narius.

On 28 April 2025, the Annual General Meeting of Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) shareholders for a new 2-years’ term re-elected five member of the previous Board – Stefan Backman, Claes Nycander, Hannu-Matti Mäkinen, Leda Iržikevičienė and Mindaugas Glodas, and newly elected Annelie Lakner. At the first meeting of the commenced term the Board re-elected Stefan Backman as Chair of the Board and appointed members of the Audit and Remuneration Committees.

New style comes with refreshed design and updated construction to maximize comfort

First wireless provider to offer next generation technology to all Canadians
Invites all Canadians to join the beta at no cost
Covers 2.5 times more square kms than any other Canadian wireless carrier
Automatically connects your phone in areas without cell service

NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition of the SmarTest® Patch to its portfolio of non-invasive drug testing solutions. The SmarTest Patch is an innovative wearable device, developed by SMARTOX®, that enables continuous drug detection through sweat over a 7 to 10-day period. The SmarTest Patch complements the Company's flagship product, the Intelligent Fingerprinting Drug Testing Solution, strengthening its product portfolio of sweat-based, non-invasive testing technologies.